Where Science Meets Strategy: Inside InSeption Group

In this episode, we sit down with Oren Gilad, President and CEO of Aprea Therapeutics, Inc., to explore the evolving landscape of precision oncology and the next generation of targeted cancer therapies. In the second half of the episode, we introduce our new strategic partner, Quartzy, the world’s leading online lab productivity platform; recap a recent event at the PABC; and discuss the U.S. Food and Drug Administration’s (FDA) approval of bepirovirsen (Hibsago) for the treatment of chronic hepatitis B (CHB) in adults.

In this episode, we sit down with Joe Arcangelo, Co-Founder and Managing Partner of InSeption Group, to explore the evolving landscape of clinical research and the challenges facing life sciences companies today.Learn more at www.inseptiongroup.com.In the second half of this episode learn more about our upcoming event on Oct. 15, new appointed leadership and Innovate in PA 2.0. Learn more about the Regional Biotechnology Conference here. 

In this episode, we sit down with the CEO of BriaCell to discuss the company’s latest developments, vision for the future and the opportunities ahead.Also, learn more about the PABC's upcoming event - the Regional Biotechnology Conference on Oct. 15. Keynote speakers include Alex Gorsky, former chairman and CEO of Johnson & Johnson and Neil Sheppard, Cofounder of BlueWhale Bio.  Learn more here. 

This episode features Jeff Marrazzo, Co-Founder of Spark Therapeutics, discussing his journey in human health and entrepreneurship. You'll also learn about the PABC’s two new board members: Mark R. Schweiker, former Governor of Pennsylvania, and J. David Owens, biotech entrepreneur and executive. 

This episode features updates about the state of biotech, NIH funding and some of the latest news shaping the biotech industry. The second half features Heather Steinman, senior vice president, business development and executive director of technology transfer at The Wistar Institute and Carole Burns, director of innovation and entrepreneurship at the Blumberg Institute. They discuss the future of tech transfer along with some key advice to our listeners.Other news - We’re proud to announce that Lou Kassa has been featured on the Philadelphia Business Journal’s Power 100 for the fourth year in a row! Read more here. 

Biotech startups depend on NIH grants that are now in doubt. How can we keep the NIH support flowing? Hear from Wistar CEO Dr. Dario Altieri and top political consultant Craig Snyder in the latest edition of Biotech Insiders with Lou Kassa.  In the second half, hear about the biotech environment with John George of the Philadelphia Business Journal.  

In this episode, we dive deep into our education programs and hear from those who make them truly unique. Dr. Scott Willett, academic director at the Blumberg Institute, manages and oversees the programs and assists hands-on with our 10-Week College Internship program and Central Bucks School District partnership. Dr. Pat Romano created and leads our Summer Two-Week Enrichment program designed for local high school students. Our second half features Dr. Nicole Geracimos, who is president of the medical staff at Penn Medicine Doylestown Health and a guest speaker during the Summer Two-Week program. To learn more about our education programs and how to support, please visit, blumberginstitute.org! 

In this episode of #Biotech Insiders, you'll hear from two amazing scientist-entrepreneurs, Nicholas Siciliano, PhD, CEO and Co-Founder of Vittoria Biotherapeutics and Josep Bassaganya-Riera, PhD, CEO and president of NImmune Biopharma, who have started extremely successful companies. We’re also thrilled that Dr. Siciliano is the Keynote Speaker at our Nov. 13 Regional Biotechnology Conference at the PABC! Interested in attending the Nov. 13 event? More can be found here! 

In this episode, we dive into the science behind Naturaz, a hair care brand built on vegan, non-GMO formulations. Mumbi Dunjwa, founder of Naturaz, discusses the company’s origin story and how Naturaz is reshaping the conversation around beauty, self-acceptance and sustainability. More on Naturaz can be found here.

In this episode, you'll hear from Frank Jones, CEO of Greene Street Pharmaceuticals, a company dedicated to advancing innovative transdermal medicine. Greene Street also plays a vital role in training the next generation of scientists by welcoming interns throughout the year.Diya Thomas, a student at Penn State University, shares her experience at the Pennsylvania Biotechnology Center (PABC) and her internship at Greene Street.